24 research outputs found

    Sonographic studies of the patient with a posterior interosseous nerve (PIN) syndrome.

    No full text
    <p>(A, B) Longitudinal study of healthy PIN (A) and the affected side (B) with significant swelling (thick arrow) before entering the supinator muscle (asterisk). (C) Transversal study with a significant swelling of the PIN (arrow) anterior to the supinator muscle. p—proximal, d—distal</p

    Patient data.

    No full text
    <p>Detailed clinical, electrodiagnostic and sonographic findings of all patients. (AD—active denervation, APD—anterior-posterior diameter, BR—brachioradialis muscle, ECR—extensor carpi radialis muscle, ECU—extensor carpi ulnaris muscle, EDC—extensor digitorum communis muscle, MRC—medical researche council, SNAP—sensory nerve action potential, SCV—sensory conduction velocity, T—triceps brachii muscle, WFE—wrist/finger extension, + mild, ++ moderate, +++ severe)</p><p>Patient data.</p

    Antero-posterior diameter (APD) of posterior interosseous nerve (PIN).

    No full text
    <p>Antero-posterior diameter (APD) of PIN in four patients shows a significant swelling of the PIN in comparison to controls. ** <i>p</i><0.001</p

    Sonographic studies of a patient with a proximal radial nerve lesion.

    No full text
    <p>(A, B) Transversal study of the posterior interosseous nerve (PIN; arrow) within the supinator muscle (asterisk) on the healthy side (A) in comparison to the affected side (B) with a significant swelling of the PIN within the muscle. (C) Longitudinal study of the PIN with a swelling before entering the Arcade of Frohse (thin arrows) and within the supinator muscle (asterisk). (D) Longitudinal study of the radial nerve in the distal upper arm with impression of the nerve (arrow) by a screw (thin arrow). p—proximal, d—distal</p

    Normative values.

    No full text
    <p>Cross sectional area (CSA) and antero-posterior diameter (APD) of the radial nerve and the posterior interosseus nerve (PIN) of 26 healthy volunteers (= 52 nerves) presented as mean ± standard deviation.</p><p>Normative values.</p

    Incidence and relative risk of stroke in the diabetic and the non-diabetic population between 1998 and 2014: A community-based stroke register

    No full text
    <div><p>One major objective of the St. Vincent Declaration was to reduce excess risk of stroke in people with diabetes mellitus. The aim of this study is to estimate the trend of incidence and relative risk of stroke in the diabetic and the non-diabetic populations in Germany over a 17-year period. We estimated age–sex standardised incidence rates of all stroke and ischaemic stroke in people with and without diabetes based on an ongoing prospective community-based stroke register covering 105,000 inhabitants. Time trends were analysed using Poisson regression. In total, 3,111 individuals (diabetes: 28.4%, men 46.9%, mean age 73.1 years (SD 13.2)) had a first stroke, 84.9% of which were ischaemic stroke. Among people with diabetes we observed a significant reduction in all stroke incidence by 1.5% per year (relative risk: 0.985; 95% confidence interval 0.972–0.9995) Likewise, this incidence tended to decrease for ischaemic stroke by 1% per year (0.993; 0.979–1.008). In contrast, the incidence rate for all stroke remained nearly stable among people without diabetes (1.003; 0.993–1.013) and for ischaemic stroke (1.002; 0.991–1.013). The relative risk comparing diabetic and non-diabetic population decreased for all stroke (two percent annual reduction) but not for ischaemic stroke. Time trends were similar for both sexes regarding all and ischaemic strokes. We found a reduction in risk of stroke in the diabetic population while this rate did not materially change in the non-diabetic population.</p></div

    Age–sex standardised incidence rate of stroke with and without diabetes in the total population.

    No full text
    <p>Continuous lines = persons with diabetes; dotted lines = persons without diabetes; x-axis: calendar year; y-axis: incidence rate per 100,000 person years.</p

    Effects of 1α,25 Dihydroxyvitamin D3 in combination with IFN beta on monocytic ILT3 and ILT4 expression.

    No full text
    <p>PBMC derived from RRMS patients (n = 9) were stimulated with 1α,25 Dihydroxyvitamin D3 (100 nM) and/or IFN beta (1000 IE) over a 48 h period. ILT3 and ILT4 protein expression on CD14+ cells was assessed by flow cytometry. The fold induction is shown (mean + SEM). A repeated measurement ANOVA with Bonferroni multiple comparison test was performed to assess statistical significance (* p<0,05; **p<0.005).</p
    corecore